Study in Prostaglandin Associated Peri-orbitopathy Switching From Prostaglandin Monotherapy to Omidenepag Isopropyl
Phase 4
- Conditions
- Normal Tension GlaucomaPrimary Open-angle GlaucomaGlaucoma, SuspectOcular Hypertension
- Interventions
- Drug: Eybelis ophthalmic solution 0.002%
- First Posted Date
- 2022-03-15
- Last Posted Date
- 2022-03-15
- Lead Sponsor
- Santen Pharmaceutical Asia Pte. Ltd.
- Target Recruit Count
- 150
- Registration Number
- NCT05279716
- Locations
- 🇰🇷
Korea University Anam Hospital, Seoul, Korea, Republic of
🇰🇷Kangbuk Samsung Hospital, Seoul, Korea, Republic of
🇰🇷Asan Medical Center, Seoul, Korea, Republic of
© Copyright 2025. All Rights Reserved by MedPath